Lv11
20 积分 2023-12-12 加入
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2小时前
已完结
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
7天前
已完结
Treatment of RET/ALK comutated advanced lung large cell neuroendocrine carcinoma: a case report and literature review
2个月前
已关闭
[Consensus on clinical diagnosis and treatment of fumarate hydratase-deficient renal cell carcinoma]
2个月前
已完结
延胡索酸水合酶缺陷型子宫平滑肌瘤25例临床病理分析
2个月前
已完结
Histologic and immunologic factors associated with response to immune checkpoint inhibitors in advanced sarcoma
4个月前
已完结
Association Between Human Epidermal Growth Factor Receptor 2-Low Status and Time to Development of Brain Metastases Among Patients With Breast Cancer: A Retrospective Cohort Study
4个月前
已完结
Response to PARP inhibitor in EGFR-tyrosine kinase inhibitor-resistant metastatic lung adenocarcinoma with germline PALB2 mutation
5个月前
已完结
中国乳腺癌PIK3CA基因突变检测专家共识(2025版)
6个月前
已完结
BRCA1/2突变和同源重组修复缺陷(HRD)检测在乳腺癌中的临床研究进展
7个月前
已完结
皖公网安备34019202002308
